Phio Pharmaceuticals Corp (PHIO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $9.21M
Last updated: Nov 17, 2026 at 11:00 AM ET
Phio Pharmaceuticals Corp (PHIO) Stock Forecast
Analysts expect Phio Pharmaceuticals (PHIO) to earn -$1.45 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.61.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$1.45
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$0.61
- EPS consensus
- Next report
- Mar 3, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$1.45 | -$1.47 to -$1.42 | 2 |
| Dec 31, 2027 | -$0.61 | -$0.77 to -$0.45 | 2 |
Quarterly Estimates
The EPS consensus rises from -$0.39 for the quarter ending Dec 31, 2026 to -$0.13 for the quarter ending Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.39 | -$0.39 to -$0.39 | 4 |
| Mar 31, 2027 | -$0.13 | -$0.13 to -$0.13 | 1 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 2 upward and 3 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 2 |
| Fiscal year ending Dec 31, 2027 | 2 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$1.38.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$1.45 | -$1.45 | -$1.45 | -$1.45 | -$1.38 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.61 | -$0.61 | -$0.61 | -$0.61 | -$0.86 | N/A |
| Quarter ending Mar 31, 2027 | -$0.13 | -$0.13 | -$0.13 | -$0.13 | -$0.20 | N/A |
Frequently Asked Questions About PHIO
What is the PHIO stock forecast?
Consensus analyst estimates put Phio Pharmaceuticals's EPS at -$1.45 for the fiscal year ending Dec 31, 2026.
What EPS do analysts expect from PHIO next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.45, with estimates from -$1.47 to -$1.42 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.61, with estimates from -$0.77 to -$0.45 from 2 analysts.
How many analysts cover PHIO?
2 analysts estimate EPS for Phio Pharmaceuticals for the fiscal year ending Dec 31, 2026.
PHIO pages: Overview, Earnings, Forecast, Financials, Competitors